Wang et al. found that the net effect of PARP inhibition on TAMs is a direct reprogramming and shift toward an anti-tumor activity, by mitigating the M2-inducing effects of IL-4, IL-10, and M-CSF [31]. Here, IL4 is linked to neoplasm.